NDC Compounded Drug 70168-0031-1 Testosterone
Pellet Subcutaneous
Compounded Drug Product Information
NDC Crossover Products Matching Testosterone
NDC crossover of Testo37.5mgchol with NDC 70168-0031 a human compounded drug with other similar products matching the same substance name (Testosterone) and the same administration route (subcutaneous) or dosage form (pellet).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
70168-0010-1 | Testo12.5mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0010-1 | Testo12.5mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0010-1 | Testo12.5mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0010-1 | Testo12.5mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0011-1 | Testo12.5mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0011-1 | Testo12.5mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0011-1 | Testo12.5mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0011-1 | Testo12.5mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0020-1 | Testo25mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0020-1 | Testo25mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0020-1 | Testo25mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0020-1 | Testo25mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0021-1 | Testo25mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0021-1 | Testo25mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0021-1 | Testo25mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0021-1 | Testo25mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0030-1 | Testo37.5mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0030-1 | Testo37.5mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0030-1 | Testo37.5mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0030-1 | Testo37.5mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0040-1 | Testo50mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0040-1 | Testo50mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0040-1 | Testo50mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0040-1 | Testo50mg | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0041-1 | Testo50mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0041-1 | Testo50mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0041-1 | Testo50mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0041-1 | Testo50mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0051-1 | Testo62.5mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
70168-0051-1 | Testo62.5mgchol | Testosterone | 1 PELLET in 1 VIAL, SINGLE-USE | Pellet | Subcutaneous | Bso, Llc |
Frequently Asked Questions
What is the NDC number assigned to Testo62.5mgchol?
Testo62.5mgchol was assigned by its manufacturer with NDC product code 70168-0031. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Testo62.5mgchol?
The NDC package code 70168-0031-1 was assigned to a 1 PELLET in 1 VIAL, SINGLE-USE of testosterone administered subcutaneous via pellet.
Who manufactures this product?
Testo62.5mgchol is manufactured by an outsourced facility and labeled by Bso, Llc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 30 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by BSO, LLC with NDC product codes 70168-0010-1, 70168-0010-1, 70168-0010-1, 70168-0010-1, 70168-0011-1, 70168-0011-1, 70168-0011-1, 70168-0011-1, 70168-0020-1, 70168-0020-1, 70168-0020-1, 70168-0020-1, 70168-0021-1, 70168-0021-1, 70168-0021-1, 70168-0021-1, 70168-0030-1, 70168-0030-1, 70168-0030-1, 70168-0030-1, 70168-0040-1, 70168-0040-1, 70168-0040-1, 70168-0040-1, 70168-0041-1, 70168-0041-1, 70168-0041-1, 70168-0041-1, 70168-0051-1 and 70168-0051-1.